The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
For years, evolutionary psychologists and biologists have investigated the idea that the shape of a man’s face can predict his behavior. A specific measurement known as the facial width-to-height ...
Dr. Àlex Bayés Puig advances SYNGAP1 research with new SynGAP biomarker study funded by CURE SYNGAP1
CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...
BioStem remains committed to advancing evidence-based innovation in wound care through rigorous clinical research and real-world data analysis, supported by its proprietary BioRetain ® process and ...
If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...
A large pharmacovigilance analysis of FDA adverse event reports shows no significant lymphoma safety signal with topical calcineurin inhibitors for atopic dermatitis.
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
The FDA has released new draft guidance outlining the use of Bayesian methodologies in clinical trials for drugs and biologics. The guidance is intended to help sponsors apply modern statistical ...
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results